DGGXF yields 12084.59% · JNJ yields 2.13%● Live data
📍 DGGXF pulled ahead of the other in Year 1
Combined, DGGXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DGGXF + JNJ for your $10,000?
DigitalX Limited provides blockchain product development and digital asset funds management services in Australia. It operates through Product Development and Asset Management segments. The Blockchain Consulting segment offers consulting, technical due diligence, and design and development solutions to businesses. This segment also develops blockchain, RegTech, and FinTech products. The Asset Management segment operates digital assets portfolio under the DigitalX Fund and DigitalX BTC Fund for high net worth and institutional investors. Its products include Drawbridge, a regtech solution that supports listed companies to manage their compliance and corporate governance policies; and Sell My Shares, an online share sales solution. The company was formerly known as Digital CC Limited and changed its name to DigitalX Limited in December 2015. DigitalX Limited was incorporated in 1988 and is headquartered in West Perth, Australia.
Full DGGXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.